FDA Pushes for New Buprenorphine Labeling ...Middle East

The FDA urges manufacturers to revise labeling of transmucosal buprenorphine products to ease access to higher doses because of the rise of high-potency opioids like fentanyl. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Pushes for New Buprenorphine Labeling )

Also on site :

• Death toll in Iran port explosion mounts to 25
• Mass shooting in Myrtle Beach tourist hotspot leaves 11 injured, suspect killed by police
• What happens after Pope Francis funeral – how the Conclave to select his successor will work